-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Revolution Medicines, Raises Price Target to $270

Benzinga·11/05/2026 20:41:04
Listen to the news
TD Cowen analyst Tyler Van Buren maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $250 to $270.